Strategic CDMO As a leading CDMO for complex biologics with AI-driven optimization and continuous bioprocessing, Just – Evotec Biologics offers a compelling partnership for biopharma companies seeking scalable development and manufacturing of mAbs, bispecifics, and biosimilars, enabling faster time-to-market and cost efficiency.

Cost Reduction Promise Leverage their J.POD facilities and in silico optimization to position for customers aiming to reduce cost of goods and expand global access to affordable biologics, highlighting potential savings in both development and manufacturing stages.

Global Access Growth Target companies pursuing global scale and reliable supply chains; Just – Evotec Biologics emphasizes agile cGMP manufacturing and rapid ramp-up capabilities to meet uncertain demand, appealing to partners with variable or accelerating demand curves.

Integrated Tech Advantage Sales teams can emphasize their tech stack and automation capabilities (Azure DevOps, Docker, Ansible, SAP SuccessFactors) as a backbone for reliable project execution, quality control, and faster collaboration with sponsors and CROs in regulated environments.

Strategic Collaborations Identify opportunities through Evotec’s broader ecosystem and past collaboration moves (immunotherapy, biotherapeutics, and Plectonic LOGIBODY collaborations) to propose joint development programs, shared risk models, or co-funded programs for novel biologics and difficult-to-manufacture modalities.